Royal Madre is a modern, hybrid-sativa cultivar developed from the genetics of Queen Mother. As a stable and well-regarded project, this strain maintains a streamlined lineage that emphasizes high yields and a moderate cultivation difficulty. Designed for success in both indoor and outdoor environments, the plant exhibits a consistent maturation period of 56 days. The influence of its parentage is evident in its reliable performance and serves as the foundational genetic source for other notable varieties such as Medical Mass.

This THC-dominant hybrid features a complex terpene profile led by caryophyllene, limonene, and nerolidol. Following these primary aromatic compounds are linalool, beta-pinene, and myrcene, which contribute to the overall sensory experience. The profile concludes with subtle notes of humulene, pinene, camphene, and bisabolol. These constituents work in combination to define the chemical character of the flower, ensuring a distinct aromatic presence that mirrors its balanced chemical composition.

Upon consumption, Royal Madre produces effects characterized as creative, elevated, and euphoric. These attributes make it an ideal choice for social interactions, tasks requiring persistent focus, or any engagement that necessitates a heightened sense of creativity. Its reliable effects and high-yield profile have established its significance within modern cultivation, further evidenced by its status as a parent to Medical Mass.